-+ 0.00%
-+ 0.00%
-+ 0.00%

ALPHA COGNITION ANNOUNCES FIRST PATIENT ENROLLED IN RESOLVE PHASE 4 STUDY EVALUATING ZUNVEYL® IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE

Reuters·06/16/2026 12:30:01

Please log in to view news